SwissNordicBio 2019
| Reference number | |
| Coordinator | VectorizeMove AB |
| Funding from Vinnova | SEK 8 333 |
| Project duration | February 2019 - March 2019 |
| Status | Completed |
Purpose and goal
The project has led to attending the SwissNordicBio 2019 and get an in-depth perspective on how pharma companies perceive medtech innovations, especially in terms of early collaborations. It has also led to kick starting discussions with other medtech companies towards strategic collaborations, geographical business opportunities, insights on raising investment rounds and EU funding opportunities.
Expected results and effects
The visit has led to high-level networking, insights into European medtech markets and EU funding opportunities.
Planned approach and implementation
Matchmaking meetings Networking meetings Attending keynotes and company pitches